The European Pharmacopoeia Commission re-evaluates its policy on the development of monographs for finished drug products. The European Pharmacopoeia (Ph.Eur.), which is celebrating its 50th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results